National Pension Service Increases Stake in Hanall Biopharma to 10.56% for Passive Investment
National Pension Service increased its stake in Hanall Biopharma from 9.32% to 10.56% as of April 3, 2026, a 1.24 percentage point rise.
The increase of 649,446 shares was acquired through open market purchases for simple investment purposes without intention to influence management.
As a highly credible institutional investor National Pension Service's expanded stake signals underlying confidence in Hanall Biopharma's fundamentals.
[AI Summary]The NPS passive stake increase adds institutional demand supporting the stock price but involves no dilution as shares are bought in secondary market. Future buying potential should be monitored for additional positive momentum.